Mosaic ImmunoEngineering
Blood & Organ Banks · California, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
1537 S Novato Blvd # 5, Novato, Californ...Phone Number
(657) 208-0890Website
www.mosaicie.comRevenue
-Stock Symbol
CPMVIndustry
About Mosaic ImmunoEngineering
Mosaic ImmunoEngineering Inc. is a Huntington Beach, California-based development-stage biotechnology company advancing a proprietary immunostimulatory platform derived from cowpea mosaic virus for cancer and infectious disease immunotherapies. Its lead candidates, administered intratumorally, aim to activate immune responses against solid tumors and enhance standard treatments such as radiation, chemotherapy, and checkpoint inhibitors. The company also develops modular vaccine applications and pursues veterinary oncology studies, supported by licensing agreements with the University of California San Diego.Explore more
Mosaic ImmunoEngineering Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Mosaic ImmunoEngineering
Compare insights from companies similar to Mosaic ImmunoEngineering, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Mosaic ImmunoEngineering
1-10
Public
-
1992
LS
Lisa SteppVice President, Patient & Government Engagement
Mosaic ImmunoEngineering Tech Stack
A closer look at the technologies used by Mosaic ImmunoEngineering
Top Blood & Organ Banks Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Mosaic ImmunoEngineering
Sign Up For FreeTo access detailed company insights
Mosaic ImmunoEngineering Inc. is a Huntington Beach, California-based development-stage biotechnology company advancing a proprietary immunostimulatory platform derived from cowpea mosaic virus for cancer and infectious disease immunotherapies. Its lead candidates, administered intratumorally, aim to activate immune responses against solid tumors a... Read More
